Veritas Reaches a Mutual Settlement with Arbutus Biopharma Corporation
July 23, 2019 17:00 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, July 23, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is pleased to announce that it has reached a...
Veritas Announces the Sale of 3 Carbon Extractions Inc.
July 10, 2019 17:00 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, July 10, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has completed the sale of...
Veritas Announces Restructuring of Cannevert Therapeutics Ltd.
May 15, 2019 17:30 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, May 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has undertaken steps to...
Veritas Announces the Completion of Clinical Trial on their Cannabis Product for Treatment of Acute Pain
May 15, 2019 08:00 ET
|
Veritas Pharma Inc.
SAN JUAN, Puerto Rico, May 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is...
Veritas Pharma Provides Corporate Update
March 27, 2019 08:00 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, March 27, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce corporate...
UPDATE -- Veritas Pharma to Commence Legal Proceedings Against Liht Cannabis
March 04, 2019 14:10 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, March 04, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has filed a claim and is...
Veritas Pharma to Commence Legal Proceedings Against Liht Cannabis
March 04, 2019 13:32 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, March 04, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has filed a claim and is...
Veritas Enrolls First Patient in Clinical Study to Assess Pain Control with Lead Product
February 22, 2019 09:43 ET
|
Veritas Pharma Inc.
SAN JUAN, Puerto Rico, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico LLC, a wholly owned subsidiary of Veritas Pharma, Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”),...
Veritas Pharma Enters into agreement to acquire Commercial Hemp and Cannabis Processing Facility
February 12, 2019 09:00 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered...
Veritas Pharma Announces the Resignation of CEO, Dr. Lui Franciosi
February 11, 2019 18:14 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces the resignation of its President,...